BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36798391)

  • 1. PI3Kδ inhibition potentiates glucocorticoids in B-lymphoblastic leukemia by decreasing receptor phosphorylation and enhancing gene regulation.
    Zimmerman JAO; Fang M; Pufall MA
    bioRxiv; 2023 Aug; ():. PubMed ID: 36798391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation.
    Zimmerman JAO; Fang M; Pufall MA
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
    Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
    Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
    Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
    J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes.
    Blind RD; Garabedian MJ
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):150-7. PubMed ID: 18304804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.
    Lynch JT; Rajendran R; Xenaki G; Berrou I; Demonacos C; Krstic-Demonacos M
    Mol Cancer; 2010 Feb; 9():38. PubMed ID: 20156337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
    Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
    Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
    He LX; Yang L; Liu T; Li YN; Huang TX; Zhang LL; Luo J; Liu CT
    Respir Res; 2023 Mar; 24(1):90. PubMed ID: 36949482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor phosphorylation differentially affects target gene expression.
    Chen W; Dang T; Blind RD; Wang Z; Cavasotto CN; Hittelman AB; Rogatsky I; Logan SK; Garabedian MJ
    Mol Endocrinol; 2008 Aug; 22(8):1754-66. PubMed ID: 18483179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
    Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM
    Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of heat shock transcription factor by GR.
    Wadekar SA; Li D; Periyasamy S; Sánchez ER
    Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
    Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
    Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
    Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
    Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
    Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
    Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14-3-3.
    Habib T; Sadoun A; Nader N; Suzuki S; Liu W; Jithesh PV; Kino T
    Mol Cell Endocrinol; 2017 Jan; 439():431-443. PubMed ID: 27717743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All).
    Bortolozzi R; Mattiuzzo E; Trentin L; Accordi B; Basso G; Viola G
    Biochem Pharmacol; 2018 Jul; 153():230-241. PubMed ID: 29408328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.